Effects of Deep Touch Pressure on Emergence Agitation in Pediatric Patients
Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · May 9, 2025
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether a method called Deep Touch Pressure (DTP) can help reduce a condition known as emergence agitation (EA) in children aged 3 to 10 years who are having their tonsils and adenoids removed while under general anesthesia. Emergence agitation can cause children to feel confused, upset, or restless when they wake up from surgery. In this trial, some children will wear a special vest that provides gentle pressure during recovery, while others will receive standard care without the vest. Researchers will compare these two groups to see if the vest helps lower the chances and intensity of emergence agitation.
To participate in the study, children must be scheduled for a tonsillectomy and adenoidectomy under general anesthesia and be between 3 to 10 years old. However, some children may not be eligible, such as those with certain neurological or skin conditions, or those who have had severe reactions to anesthesia in the past. If a child is part of the study and experiences significant agitation, they will receive medication to help calm them. This research aims to find out if using DTP is a safe and effective way to help young patients have a smoother recovery after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Pediatric patients aged 3 to 10 years scheduled for tonsillectomy and adenoidectomy under general anesthesia.
- Exclusion Criteria:
- • Emergency surgery.
- • Known neurological disorders (e.g., epilepsy, cerebral palsy).
- • Skin disorders or injuries on the chest or upper body that prevent safe use of the compression vest (HUGgy).
- • History of severe psychiatric disorders (e.g., autism spectrum disorder, severe anxiety disorder).
- • History of severe allergic reactions to anesthesia.
- • Any condition that, in the investigator's judgment, makes the patient unsuitable for the study.
About Seoul National University Hospital
Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported